Lale Kostakoglu, MD, MPH

home / authors / lale-kostakoglu-md-mph

Articles

Site Logo

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma

Bruce D. Cheson, MD;Lale Kostakoglu, MD, MPH
January 15th 2017

Here we critically analyze the role of PET/CT in the early assessment of Hodgkin lymphoma.

Site Logo

FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation

Bruce D. Cheson, MD;Lale Kostakoglu, MD, MPH
January 15th 2017

Here we review the role of interim PET/CT in diffuse large B-cell lymphoma (DLBCL), and also explore the question of whether new approaches to quantitative assessment improve the prognostic value of interim PET scans in both Hodgkin lymphoma and DLBCL.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: November 18th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Pancreatic Mass Found in 43-Year-Old Patient
Published: July 26th 2016 | Updated: November 18th 2024
Pancreatic Mass Found in 43-Year-Old Patient
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases
Published: July 31st 2012 | Updated: November 18th 2024
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases